June 02, 2017
In re EpiPen ERISA Litigation (Klein et al v. Prime Therapeutics, LLC et al)
Case Number:
0:17-cv-01884
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Alston & Bird
- Berman Tabacco
- Bradford & Wilson
- Burns Charest
- Dorsey & Whitney
- Edelsberg Law
- Ellis George
- Faegre Drinker
- Keller Rohrback
- Lanier Law Firm
- Lockridge Grindal
- Mayer Brown
- Quinn Emanuel
- Robbins Geller
- Sharp Law LLP
- Spencer Fane
- Steptoe LLP
- Stinson LLP
- Williams & Connolly
- Zimmerman Reed
Companies
- CVS Health Corp.
- Express Scripts Holding Co.
- Medco Health Solutions Inc.
- Optum Inc.
- OptumRx Inc.
- UnitedHealth Group Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 05, 2020
EpiPen Buyers Lose Bid For Class Status In ERISA Suit
A Minnesota federal judge denied class certification to EpiPen buyers Wednesday in a suit accusing Express Scripts, CVS Health and other pharmacy benefit managers of violating the Employee Retirement Income Security Act by causing plan participants to overpay for the device.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login